RxDoctor Payments Data

Aaron Hoekje

Medical · Waynesburg, PANPI 1538307335

Payments from drug & device makers

$2,833in general payments, 2019–2025

Across 168 payments — averaging $16.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$530
  • Lilly USA, LLC$355
  • AstraZeneca$309
  • Boehringer Ingelheim$263
  • Novo Nordisk$253
  • Amgen$180
  • plus $943 from 21 others

What the payments were for

  • Food & beverage$2,822100%
  • Education$120%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,833 in reported general payments places this provider in the 80th percentile of 2,594 medical providers in Pennsylvania.

See all medical providers in Pennsylvania

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide174$221,948
JardianceEmpagliflozin116$153,410
EliquisApixaban63$74,384
TrulicityDulaglutide37$52,455
Trelegy ElliptaFluticasone/Umeclidin/Vilanter30$33,413
OzempicSemaglutide33$31,569
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog24$30,845
Breztri AerosphereBudesonide/Glycopyr/Formoterol28$28,632
FarxigaDapagliflozin Propanediol20$23,769
Repatha SureclickEvolocumab21$23,715
JanumetSitagliptin Phos/Metformin Hcl20$21,121
Synjardy XrEmpagliflozin/Metformin Hcl22$20,872
JanuviaSitagliptin Phosphate18$16,539
Breo ElliptaFluticasone/Vilanterol37$14,798
Tresiba Flextouch U-100Insulin Degludec20$14,312

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$355$274,402211 claims
Boehringer IngelheimJardiance, Synjardy Xr, Trijardy Xr$263$180,836149 claims
PfizerEliquis$121$74,38463 claims
AstraZenecaBreztri Aerosphere, Farxiga, Symbicort$309$60,30469 claims
GSKTrelegy Ellipta, Breo Ellipta, Incruse Ellipta$17$56,82281 claims
MerckJanumet, Januvia$114$37,66038 claims
Novo NordiskOzempic$253$31,56933 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 2,594 medical providers in Pennsylvania.

Other medical in Waynesburg

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →